Page 2

You are here:

Page 2

Group Ketamine-Assisted Psychotherapy (KAP): A New Frontier

Posted on April 23, 2021 by Emma Bragdon

Could taking and integrating ketamine in groups make psychedelic therapy more accessible? This blog explores what happens in the group and why it’s effective. The following is an abridged version of an article written by Sean Lawlor, published by Psychedelics Today in March 2021. As psychedelic-assisted therapy continues marching into the mainstream, the

Posted in Integrative Mental Health, Psychedelics, Uncategorized group ketamine-assisted psychotherapy, group therapy, ketamine, ketamine-assisted psychotherapy, psychedelic medicine, psychedelics, Scott Shannon

Ketamine-Assisted Psychotherapy

Posted on April 15, 2021 by Emma Bragdon

The drug, Ketamine, in moderate doses, is now being used legally to effectively help people out of anxiety, depression and the effects of trauma, PTSD. Best usage comes when the medicine is given alongside psychotherapy with a trained psychotherapist present. The MD needs to be in charge of dosage given to empower the psychotherapy and

Posted in Integrative Mental Health, Psychedelics ketamine, psychedelic-assisted therapy, psychotherapy, stan grof, Will Siu

UC Berkeley’s New Center for Psychedelic Science and Education

Posted on September 30, 2020 by Emma Bragdon

Fifty years after political and cultural winds slammed shut the doors on psychedelic research, UC Berkeley is making up for lost time by launching the campus’s first center for psychedelic science and public education. With $1.25 million in seed funding from an anonymous donor, the new UC Berkeley Center for the Science of Psychedelics

Posted in Integrative Mental Health, Psychedelics Johns Hopkins, Michael Pollan, psychedelic, psychedelic research, psychedlic-assisted psychotherapy, UC Berkeley